COG3

protein-coding

component of oligomeric golgi complex 3, the group of Components of oligomeric golgi complex

Gene summary

This gene encodes a component of the conserved oligomeric Golgi (COG) complex which is composed of eight different subunits and is required for normal Golgi morphology and localization. Defects in the COG complex result in multiple deficiencies in protein glycosylation. The protein encoded by this gene is involved in ER-Golgi transport.[provided by RefSeq, Jun 2011]

MANE transcript

NM_031431.4

Inheritance

AR

ClinVar variants

U:101B:2

Top phenotype

Congenital disorder of glycosylation, type IIbb

gnomAD constraint

pLI —, LoF o/e 0.1

Max pathogenic AF

—

Genomic locus

chr13:45,464,898-45,536,701

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~71.8 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

congenital disorder of glycosylationLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0015286

Submitter: ClinGen

*COG3* was first reported in relation to an autosomal recessive congenital disorder of glycosylation in 2023 (Duan et al., PMID: 37711075). Two families have been reported with biallelic variants in the gene. These individuals presented with global developmental delay and severe intellectual disability, microcephaly, epilepsy, facial dysmorphism, and variable neurological findings. Serum transferrin studies, carried out for affected individuals in one of the families showed reduced sialylation. Congenital Disorder of Glycosylation (specifically Congenital disorder of glycosylation, type IIbb, MIM# 606975; also known as COG3-CDG) is the only monogenic disorder asserted to be caused by variants in *COG3*. Two different missense variants have been reported, each in one of the two reported families (Duan et al, 2023, PMID: 37711075). The mechanism of disease is unknown but assumed to be loss of function. (Total points for genetic evidence = 1.5 points) This gene-disease relationship is also supported by experimental evidence including the biochemical function of COG3, a subunit of the COG complex, which is important in intra Golgi and Golgi to ER retrograde transport (Zolov and Lupashin, 2005, PMID: 15728195; Shestakova et al, 2006, PMID: 16420527), protein interaction studies showing physical interaction of COG3 with other COG subunits that have been implicated in CDG (Lees et al, 2010, PMID: 20972446; Ishii et al, 2018, PMID: 29899178), and functional alteration studies in patient and non-patient cells showing defects in retrograde transport (Duan et al, 2023, PMID: 37711075; Pokrovskaya et al, 2011, PMID: 21421995). (Total points for experimental evidence = 5 points). In summary, there is limited evidence supporting the relationship between *COG3* and an autosomal recessive congenital disorder of glycosylation. This classification was approved by the ClinGen Congenital Disorders of Glycosylation Gene Curation Expert Panel on September 18, 2024 (SOP Version #11)

congenital disorder of glycosylation, type IIbbLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0957820

Submitter: Ambry Genetics

Clinical Genomic Database (CGD)

Congenital disorder of glycosylation, type IIbbAR

Manifestation: Craniofacial; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 37711075Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to COG3 variants in ClinVar

3 Conditions Cataloged
not specifiedTotal: 88
Congenital disorder of glycosylation, type IIbbTotal: 3
not providedTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_031431.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
2
missense
95
clinvar
2
clinvar
97
nonsense
1
clinvar
1
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
3
clinvar
3
Total0010120103
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 35 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_031431.4RefSeqNP_113619.323MANE Select
ENST00000349995.10EnsemblENSP00000258654.823MANE Select
ENST00000476702.1EnsemblENSP00000482221.12Standard
ENST00000486940.2EnsemblENSP00000477882.13Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Vesicle-mediated transport
  • Membrane Trafficking
  • Post-translational protein modification
  • Metabolism of proteins
  • Transport to the Golgi and subsequent modification

Biological Process

  • protein glycosylation
  • intracellular protein transport
  • endoplasmic reticulum to Golgi vesicle-mediated transport
  • retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
  • intra-Golgi vesicle-mediated transport

Molecular Function

  • protein binding
  • protein transporter activity

Cellular Component

  • Golgi membrane
  • Golgi apparatus
  • cis-Golgi network
  • cytosol
  • plasma membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000349995
Coding exons
23
Length
71706
Individuals with no LoFs
125725
Homozygous LoFs
0
Heterozygous LoFs
23
Defined
125748
p
0.0000915
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.573314220.7850.00002045404
Missense (PolyPhen)86130.190.660591670
Synonymous0.9491511670.9060.000008671537
Loss of Function5.84549.20.1020.00000230628

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000880.000087rare
Ashkenazi Jewish0.000100.000099rare
East Asian00.0absent
Finnish0.000320.00032rare
European (Non-Finnish)0.0000540.000053rare
South Asian0.000290.00016rare
Other0.000160.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Involved in ER-Golgi transport. {ECO:0000269|PubMed:11929878}.;

Recessive Scores

pRec
0.119

Intolerance Scores

RVIS EVS
-0.27
RVIS percentile EVS
34.82

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
E
Essential (gene trap)
E
Indispensability pred.
E
Indispensability score
0.916

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.